The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.
Abstract
This study compared the efficacy of 3 16-week treatments for depression in 63 patients with multiple sclerosis (MS) and major depressive disorder (MDD): individual cognitive-behavioral therapy (CBT), supportive-expressive group therapy (SEG). and the antidepressant sertraline. Significant reductions were seen from pre- to posttreatment in all measures of depression. Intent-to-treat and completers analyses using the Beck Depression Inventory (BDI; A. T. Beck, C. H. Ward. M. Medelson. J. Mock, & J. Erbaugh, 1961) and MDD diagnosis found that CBT and sertraline were more effective than SEG at reducing depression. These results were largely supported by the BDI-18, which eliminates BDI items confounded with MS. However, the Hamilton Rating Scale for Depression (M. Hamilton, 1960) did not show consistent differences between treatments. Reasons for this inconsistency are discussed. These findings suggest that CBT or sertraline is more likely to be effective in treating MDD in MS compared with supportive group treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Controlled trials of behavioral interventions among patients with MS have focused upon treatment of depression, fatigue, or anxiety in patients selected for high symptom severity.16–18”
From MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial (2010) · cites this paper as [16]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Littell, R. C. (1996) · Medical Entomology and Zoology · Cited by 10,345
Cognitive Therapy for Depression
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,678
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
A compendium of neuropsychological tests: administration, norms, and commentary
(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,118
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Levin, H. S. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050007005 · Cited by 4,796
Cognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Research works printed but not linked: 11
- Classen, 1993, Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual.
- Cohen-Cole, 1987, Diagnostic assessment of depression in the medically ill., 23
- 10.1037/0022-006X.67.3.285 · DOI
- Mohr, 1998, Multiple sclerosis., 313
- 10.1093/clipsy/6.1.1 · DOI
- 10.1037/0022-006X.68.2.356 · DOI · Paper page
- 10.1037/0278-6133.18.4.383 · DOI
- Smith, 1982, Symbol Digit Modalities Test (SDMT) manual (revised).
- Spiegel, 2000, Group psychotherapy for cancer patients.
- 10.1037/0022-006X.54.3.381 · DOI · Paper page
- Wechsler, 1987, Wechsler Memory Scale--Revised manual.
Cited by
Sorted by citations
Items 101–200 of 334
Chalk, H. M. (2007) · Psychology Health & Medicine · doi:10.1080/13548500701244965 · Cited by 55
Fernie, B. A., Kollmann, J., & Brown, R. G. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.02.012 · Cited by 51
Dennhag, I., Gibbons, M. B. C., Barber, J. P., Gallop, R., & Crits-Christoph, P. F. (2012) · Psychotherapy Research · doi:10.1080/10503307.2012.674790 · Cited by 51
Mackin, R. S., Nelson, J. C., Delucchi, K., Raue, P. J., Byers, A. L., Barnes, D. E., Satre, D. D., Yaffe, K. S., Alexopoulos, G. S., & Areán, P. A. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.11.002 · Cited by 51
Mohr, D., & Genain, C. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00601-9 · Cited by 50
Self-citationCristea, I. A., Ștefan, S., Karyotaki, E., David, D., Hollon, S. D., & Cuijpers, P. J. (2017) · Psychological Bulletin · doi:10.1037/bul0000062 · Cited by 55
Kiropoulos, L. A., Kilpatrick, T., Holmes, A., & Threader, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1152-7 · Cited by 50
Pouyanfard, S., Mohammadpour, M., ParviziFard, A. A., & Sadeghi, K. (2020) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2018-0105 · Cited by 49
Cole, K., & Vaughan, F. L. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.03.002 · Cited by 49
Howard, I., Turner, R., Olkin, R., & Mohr, D. C. (2006) · Journal of Clinical Psychology · doi:10.1002/jclp.20274 · Cited by 48
Self-citationPalliative Care in Amyotrophic Lateral Sclerosis, Parkinson's Disease, and Multiple Sclerosis
Elman, L. B., Houghton, D. J., Wu, G. F., Hurtig, H. I., Markowitz, C., & McCluskey, L. F. (2007) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9978 · Cited by 47
Treatment of depression in people who have multiple sclerosis
Sollom, A. C., & Kneebone, I. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507072384 · Cited by 48
Claflin, S. B., van der Mei, I. A. F., & Taylor, B. V. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314490 · Cited by 51
Cosio, D., Jin, L., Siddique, J., & Mohr, D. C. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9236-y · Cited by 49
Self-citationNunnari, D., Cola, M. C. D., D’Aleo, G., Rifici, C., Russo, M., Sessa, E., Bramanti, P., & Marino, S. (2015) · BioMed Research International · doi:10.1155/2015/519785 · Cited by 46
Heckman, T. G., Heckman, B. D., Anderson, T., Lovejoy, T. I., Mohr, D. C., Sutton, M., Bianco, J. A., & Gau, J. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0441-0 · Cited by 47
Self-citationMohr, D. C., Burke, H., Beckner, V., & Merluzzi, N. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1150oa · Cited by 46
Self-citationOmega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study
Shinto, L. H., Marracci, G., Mohr, D. C., Bumgarner, L., Murchison, C., Senders, A., & BOURDETTE, D. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147195 · Cited by 47
Self-citationPsychosocial interventions in people with multiple sclerosis
Malcomson, K. S., Dunwoody, L., & Lowe-Strong, A. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0349-y · Cited by 50
Scott, A. J., Bisby, M. A., Heriseanu, A. I., Salameh, Y., Karin, E., Fogliati, R., Dudeney, J., Gandy, M., McLellan, L. F., Wootton, B., et al. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102353 · Cited by 45
Review: Brain—immune communication psychoneuroimmunology of multiple sclerosis
Kern, S., & Ziemssen, T. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507079657 · Cited by 45
Nathoo, N., & Mackie, A. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.10.004 · Cited by 48
Cuijpers, P., Karyotaki, E., Andersson, G., Li, J., Mergl, R., & Hegerl, U. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.06.005 · Cited by 44
Depression and neurological disorders
Benedetti, F., Bernasconi, A., & Pontiggia, A. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000194147.88647.7f · Cited by 45
Clinical correlates of CES-D depressive symptom ratings in an MS population
Patten, S. B., Lavorato, D. H., & Metz, L. M. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.010 · Cited by 43
Affective mediators of a physical activity intervention for depression in multiple sclerosis.
Kratz, A. L., Ehde, D. M., & Bombardier, C. H. (2014) · Rehabilitation Psychology · doi:10.1037/a0035287 · Cited by 42
Beckner, V., Howard, I., Vella, L., & Mohr, D. C. (2009) · Journal of Behavioral Medicine · doi:10.1007/s10865-009-9235-2 · Cited by 45
Self-citationFisher, P., Salmon, P., Heffer-Rahn, P., Huntley, C., Reilly, J., & Cherry, M. G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.073 · Cited by 42
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients
Solaro, C. M., Bergamaschi, R., Rezzani, C., Mueller, M., Trabucco, E., Bargiggia, V., Dematteis, F., Mattioda, A., Cimino, V., Restivo, D. A., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182996400 · Cited by 39
Peres, D. S., Theisen, M. C., Fialho, M. F. P., Dalenogare, D. P., Rodrigues, P., Kudsi, S. Q., Bernardes, L. D. B., Ruviaro, N. A., Lückemeyer, D. D., Sampaio, T. B., et al. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.07.011 · Cited by 39
Burns, M. N., Nawacki, E., Siddique, J., Pelletier, D., & Mohr, D. C. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182757b2b · Cited by 37
Self-citationCristea, I. A., Karyotaki, E., Hollon, S. D., Cuijpers, P., & Gentili, C. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.022 · Cited by 34
Cristea, I. A., Gentili, C., Pietrini, P., & Cuijpers, P. J. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.179275 · Cited by 35
Xie, J., He, G., Ding, S., Pan, C., Zhang, X., Zhou, J., & Iennaco, J. D. (2017) · Psychotherapy Research · doi:10.1080/10503307.2017.1364444 · Cited by 37
Antidepressants for neuro-regeneration: from depression to Alzheimer’s disease
Kim, H., Kim, W., & Kong, S.-Y. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0238-8 · Cited by 35
Challenges in screening for depression in multiple sclerosis
Patten, S. B., Berzins, S., & Metz, L. M. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510377770 · Cited by 33
Fluvoxamine Treatment of Major Depression Associated With Multiple Sclerosis
Benedetti, F., Campori, E., Colombo, C., & Smeraldi, E. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.364 · Cited by 33
Major depressive disorders accompanying autoimmune diseases – Response to treatment
Białek, K. I., Czarny, P. L., Strycharz, J., & Śliwiński, T. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109678 · Cited by 34
Elliott, T. R., & Jackson, W. T. (2006) · Springer eBooks · doi:10.1007/0-306-48581-8_91 · Cited by 33
Askey-Jones, S., David, A. S., Silber, E., Shaw, P., & Chalder, T. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.04.001 · Cited by 32
Cognitive Dysfunction in Multiple Sclerosis
Glanz, B. I., & Houtchens, M. K. (2012) · Wiley eBooks · doi:10.1002/9781119963714.ch10 · Cited by 32
Depression in Persons with Multiple Sclerosis
Ehde, D. M., & Bombardier, C. H. (2005) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2005.01.010 · Cited by 31
A Framework of Care in Multiple Sclerosis, Part 2
Newsome, S. D., Aliotta, P. J., Bainbridge, J. L., Bennett, S. E., Cutter, G., Fenton, K. M., LUBLIN, F. D., Northrop, D. E., Rintell, D. J., Walker, B. D., et al. (2017) · International Journal of MS Care · doi:10.7224/1537-2073.2016-062 · Cited by 30
Internet-based treatment for depression in multiple sclerosis: A randomized controlled trial
Boeschoten, R., Dekker, J., Uitdehaag, B., Beekman, A., Hoogendoorn, A., Collette, E., Cuijpers, P., Nieuwenhuis, M. M., & van Oppen, P. (2017) · Multiple Sclerosis · doi:10.1177/1352458516671820 · Cited by 24
Symptomatic Therapy and Rehabilitation in Primary Progressive Multiple Sclerosis
Khan, F., Amatya, B., & Turner‐Stokes, L. F. (2011) · Neurology Research International · doi:10.1155/2011/740505 · Cited by 29
Impact and characteristics of quality of life in Japanese patients with multiple sclerosis
Kikuchi, H., Mifune, N., Niino, M., Ohbu, S., Kira, J., Kohriyama, T., Ota, K., Tanaka, M., Ochi, H., Nakane, S., et al. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9725-2 · Cited by 30
Wollin, J. A., Spencer, N., McDonald, E., Fulcher, G., Bourne, M., & Simmons, R. D. (2013) · International Journal of MS Care · doi:10.7224/1537-2073.2012-032 · Cited by 28
Conroy, S. K., Brownlowe, K. B., & McAllister, T. W. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200004 · Cited by 30
Treatment of Mood Disorders in Multiple Sclerosis
Pintor, L., Sánchez, R., & Lázaro, E. B. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0323-4 · Cited by 29
Patient Health Questionnaire-9 to Screen for Depression in Outpatients With Multiple Sclerosis
Ferrando, S. J., Samton, J., Mor, N., Nicora, S., Findler, M., & Apatoff, B. (2007) · International Journal of MS Care · doi:10.7224/1537-2073-9.3.99 · Cited by 28
Moss-Morris, R. E., Dennison, L., Yardley, L., Landau, S., Roche, S., McCrone, P., & Chalder, T. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-45 · Cited by 29
Co-occurring Depression and Pain in Multiple Sclerosis
Alschuler, K. N., Ehde, D. M., & Jensen, M. P. (2013) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2013.06.001 · Cited by 28
Symptomatische Therapie der Multiplen Sklerose
Henze, T. (2004) · psychoneuro · doi:10.1055/s-2004-831085 · Cited by 27
Antidepressiva zur Behandlung der Depression bei Palliativpatienten
Ujeyl, M., & Müller-Oerlinghausen, B. (2012) · Der Schmerz · doi:10.1007/s00482-012-1221-x · Cited by 26
Calonge, A. A., Ruiz‐Palomino, P., & Sáez‐Martínez, F. J. (2022) · Cogent Business & Management · doi:10.1080/23311975.2022.2140745 · Cited by 29
Clinical Practice Guidelines for the Detection and Treatment of Depression in Multiple Sclerosis
McIntosh, G. E., Liu, E. S., Allan, M., & Grech, L. (2023) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200154 · Cited by 28
Dennison, L., Moss-Morris, R., Yardley, L., Kirby, S., & Chalder, T. (2013) · Psychology and Health · doi:10.1080/08870446.2013.767904 · Cited by 30
Mohr, D. C., Epstein, L. A., Luks, T. L., Goodkin, D. E., Cox, D., Goldberg, A., Chin, C. T., & Nelson, S. J. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.6.1017 · Cited by 25
Self-citationCoping with Multiple Sclerosis: Considerations and Interventions
McNulty, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-48670-3_14 · Cited by 25
A Randomized Placebo-Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis
Brown, T. R., & Slee, A. E. (2014) · International Journal of MS Care · doi:10.7224/1537-2073.2014-001 · Cited by 25
Tröger, A., Miguel, C., Čihařová, M., de Ponti, N., Durman, G., Cuijpers, P. J., & Karyotaki, E. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.047 · Cited by 24
Kraemer, M., Herold, M., UEKERMANN, J., Kis, B., Daum, I., Wiltfang, J., Berlit, P., Diehl, R. R., & Abdel‐Hamid, M. (2012) · Journal of Neuropsychology · doi:10.1111/j.1748-6653.2012.02037.x · Cited by 24
Setting the agenda for multiple sclerosis rehabilitation research
Kraft, G., Johnson, K., Yorkston, K. M., Amtmann, D., Bamer, A. M., Bombardier, C. H., Ehde, D. M., Fraser, R., & Starks, H. E. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508093891 · Cited by 24
Firth, N. (2013) · Journal of Health Psychology · doi:10.1177/1359105313479630 · Cited by 23
Heffer-Rahn, P., & Fisher, P. L. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.11.014 · Cited by 22
Patients' perspectives on quality of mental health care for people with MS
Rintell, D. J., Frankel, D., Minden, S. L., & Glanz, B. I. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.04.001 · Cited by 28
Les troubles de l’humeur et des émotions dans la sclérose en plaques : une revue de la littérature
Montel, S., & Bungener, C. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)90352-5 · Cited by 17
REVIEW OF INTERVENTION STUDIES ON DEPRESSION IN PERSONS WITH MULTIPLE SCLEROSIS
Walker, I., & Gonzalez, E. W. (2007) · Issues in Mental Health Nursing · doi:10.1080/01612840701344480 · Cited by 21
Boeschoten, R. E., Dekker, J., Uitdehaag, B. M. J., Polman, C. H., Collette, E. H., Cuijpers, P. J., Beekman, A. T. F., & van Oppen, P. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-137 · Cited by 24
Boeschoten, R. E., Nieuwenhuis, M. M., van Oppen, P., Uitdehaag, B. M. J., Polman, C. H., Collette, E. H., Cuijpers, P. J., Beekman, A. T. F., & Dekker, J. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.016 · Cited by 24
Serotonin in Neurological Diseases
Dorszewska, J., Florczak‐Wyspianska, J., Kowalska, M., Stański, M., Kowalewska, A., & Kozubski, W. P. (2017) · InTech eBooks · doi:10.5772/intechopen.69035 · Cited by 21
Disease Management for Depression in an Ms Clinic
Patten, S. B., Newman, S. C., Becker, M., Riddell, C., & Metz, L. M. (2007) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.37.4.h · Cited by 22
Hadinia, A., Meyer, A., Bruegger, V., Hatz, F., Nowak, K., Taub, E., Nyberg, E., Stieglitz, R.-D., Fuhr, P., & Gschwandtner, U. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01975 · Cited by 20
“Even in elderly patients (Peng et al., 2001; Ceri, 2007) and in patients with neurological diseases, positive effects such as a reduction of depressive symptoms have been reported (Mohr et al., 2001, 2004).”
BackgroundMethodBehavioral Interventions in Multiple Sclerosis.
Turner, A. P., & Knowles, L. M. (2020) · PubMed · Cited by 23
Current perspectives on co-morbid depression and multiple sclerosis
Patten, S. B. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1806062 · Cited by 20
Patten, S. B., Williams, J., & Metz, L. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507082942 · Cited by 20
Cognitive Reserve Attenuates the Effect of Disability on Depression in Multiple Sclerosis
Cadden, M. H., Guty, E. T., & Arnett, P. A. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acy067 · Cited by 19
The emotional disorders associated with multiple sclerosis
Raimo, S., Santangelo, G., & Trojano, L. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-822290-4.00009-8 · Cited by 20
Lucien, A., Francis, H., Wu, W., Woldhuis, T., & Gandy, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105858 · Cited by 24
Bhattacharjee, S., Goldstone, L. W., Ip, Q., & Warholak, T. L. (2017) · Multiple Sclerosis International · doi:10.1155/2017/3175358 · Cited by 19
An Integrated Model of Group Psychotherapy for Patients with Fibromyalgia
Anderson, F. J., & Winkler, A. E. (2007) · International Journal of Group Psychotherapy · doi:10.1521/ijgp.2007.57.4.451 · Cited by 18
Individual Face-to-Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study
Gottberg, K., Chruzander, C., Backenroth, G., Johansson, S., Ahlström, G., & Ytterberg, C. (2016) · Journal of Clinical Psychology · doi:10.1002/jclp.22288 · Cited by 21
Hampson, N., King, L., Eriksson, L.-M., & Smee, H. (2019) · Disability and Rehabilitation · doi:10.1080/09638288.2018.1554009 · Cited by 17
The Recognition and Management of Psychological Reactions to Stroke
Chriki, L. S., Bullain, S., & Stern, T. A. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0407 · Cited by 17
Patel, V. P., & Feinstein, A. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518770086 · Cited by 17
Rational antidepressant selection: applying evidence-based medicine to complex real-world patients.
Zetin, M., Hoepner, C. T., & Bjornson, L. (2006) · PubMed · Cited by 17
Miner, A. S., Schueller, S. M., Lattie, E. G., & Mohr, D. C. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.033 · Cited by 17
Self-citationOžura, A., & Šega, S. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.014 · Cited by 16
The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series
Carrigan, N., Dysch, L., & Salkovskis, P. M. (2017) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246581700056x · Cited by 16
Motivation-Matched Approach to the Treatment of Problem Gambling: A Case Series Pilot Study
Stewart, M. J., MacNevin, P. D., Hodgins, D. C., Barrett, S. P., Swansburg, J. E., & Stewart, S. H. (2016) · Journal of Gambling Issues · doi:10.4309/jgi.2016.33.8 · Cited by 15
Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care
Turcotte, L., Marrie, R. A., Patten, S. B., & Hirdes, J. P. (2017) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2017.274 · Cited by 15
Computerized Cognitive Behavioral Therapy for Treatment of Depression in Multiple Sclerosis
Ratajska, A. M., Zurawski, J. D., Healy, B. C., & Glanz, B. I. (2018) · International Journal of MS Care · doi:10.7224/1537-2073.2017-094 · Cited by 16
Visschedijk, M. A. J., Collette, E. H., Pfennings, L. E. M. A., Polman, C. H., & van der Ploeg, H. M. (2004) · Psychological Reports · doi:10.2466/pr0.95.3.735-746 · Cited by 15
Update on depression in neurologic illness: Stroke, epilepsy, and multiple sclerosis
Sobel, R. M., Lotkowski, S., & Mandel, S. M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0043-2 · Cited by 15
Is the Exposome Involved in Brain Disorders through the Serotoninergic System?
Sarrouilhe, D., Defamie, N., & Mesnil, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101351 · Cited by 17
Muñoz San José, A., Oreja-Guevara, C., Cebolla Lorenzo, S., Carrillo Notario, L., Rodríguez Vega, B., & Bayón Pérez, C. (2016) · Neurología · doi:10.1016/j.nrl.2015.07.014 · Cited by 14
José, A. M. S., Oreja‐Guevara, C., Lorenzo, S. C., Notario, L. C., Vega, B. R., & Pérez, C. B. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.07.003 · Cited by 15
Interdisciplinary Treatment of Patients with Multiple Sclerosis and Chronic Pain
Sullivan, A. B., Scheman, J., LoPresti, A., & Prayor-Patterson, H. (2012) · International Journal of MS Care · doi:10.7224/1537-2073-14.4.216 · Cited by 14
Joffe, R. T. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0501 · Cited by 14
Kasatkin, D. S., & Спирин, Н. А. (2007) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-007-0004-9 · Cited by 14
Metadata
- Authors
- Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L.
- Affiliations
- University of California, San Francisco (US)
- Kaiser Permanente (US)
- University of California Office of the President (US)
- ORCID
- Mohr, David C.
- Venue
- Journal of Consulting and Clinical Psychology
- Published
- 2001
- Volume
- 69
- Issue
- 6
- Pages
- 942-949
- ISSN
- 0022-006X (ISSN-L)
- 1939-2117
- OpenAlex
- W2028940268
- Cited by
- 334
- References
- 84
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 2 · 2021: 9 · 2020: 11 · 2019: 11 · 2018: 8 · 2017: 24 · 2016: 19 · 2015: 20 · 2014: 13 · 2013: 24 · 2012: 23
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Consulting and Clinical Psychology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01-MH59708, R01MH059708)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, multiple sclerosis, major depressive disorder, cognitive behavioral therapy, supportive-expressive group therapy, sertraline, antidepressant treatment, treatment efficacy comparison, Beck Depression Inventory, Hamilton Depression Rating Scale
- MeSH terms
- Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Male, Multiple Sclerosis, Psychotherapy, Group, Surveys and Questionnaires, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review